Thalamic atrophy measured by artificial intelligence in a multicentre clinical routine real-world study is associated with disability progression

18Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background The thalamus is a key grey matter structure, and sensitive marker of neurodegeneration in multiple sclerosis (MS). Previous reports indicated that thalamic volumetry using artificial intelligence (AI) on clinical-quality T2-fluid-attenuated inversion recovery (FLAIR) images alone is fast and reliable. Objective To investigate whether thalamic volume (TV) loss, measured longitudinally by AI, is associated with disability progression (DP) in patients with MS, participating in a large multicentre study. Methods The DeepGRAI (Deep Grey Rating via Artificial Intelligence) Registry is a multicentre (30 USA sites), longitudinal, observational, retrospective, real-world study of relapsing-remitting (RR) MS patients. Each centre enrolled between 30 and 35 patients. Brain MRI exams acquired at baseline and follow-up on 1.5T or 3T scanners with no prior standardisation were collected. TV measurement was performed on T2-FLAIR using DeepGRAI, and on two dimensional (D)-weighted and 3D T1-weighted images (WI) by using FMRIB's Integrated Registration and Segmentation Tool software where possible. Results 1002 RRMS patients were followed for an average of 2.6 years. Longitudinal TV analysis was more readily available on T2-FLAIR (96.1%), compared with 2D-T1-WI (61.8%) or 3D-T1-WI (33.2%). Over the follow-up, DeepGRAI TV loss was significantly higher in patients with DP, compared with those with disability improvement (DI) or disease stability (-1.35% in DP,-0.87% in DI and-0.57% in Stable, p=0.045, Bonferroni-adjusted, age-adjusted and follow-up time-adjusted analysis of covariance). In a regression model including MRI scanner change, age, sex, disease duration and follow-up time, DP was associated with DeepGRAI TV loss (p=0.022). Conclusions Thalamic atrophy measured by AI in a multicentre clinical routine real-world setting is associated with DP over mid-term follow-up.

Author supplied keywords

Cite

CITATION STYLE

APA

Zivadinov, R., Bergsland, N., Jakimovski, D., Weinstock-Guttman, B., Benedict, R. H. B., Riolo, J., … Dwyer, M. G. (2022). Thalamic atrophy measured by artificial intelligence in a multicentre clinical routine real-world study is associated with disability progression. Journal of Neurology, Neurosurgery and Psychiatry, 93(10), 1128–1136. https://doi.org/10.1136/jnnp-2022-329333

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free